8 / 15
Page 50
conferenceseries
.com
Volume 6, Issue 6 (Suppl)
OMICS J Radiol, an open access journal
ISSN: 2167-7964
Neuroradiology 2017
October 30 to November 01, 2017
October 30 to November 01, 2017 | San Antonio, USA
2
nd
International Conference on
Neuroscience, Neuroimaging & Interventional Radiology
A brief review of the advances in endovascular therapy and the recent recommendations of AHA/ASA for
stroke treatments
Joaquin Jose Marenco De La Torre
State University of Rio de Janeiro, Brazil
S
troke is the second cause of death in the USA and responsible for several sequelae that reduce the quality of life of those who survive.
Several treatment strategies have arisen, bringing new perspectives to patients and physicians. These advances were possible due
to the recognition by the world medical societies of the stroke as a potentially reversible event. Rapid treatment with fibrinolysis has
been the standard of care in these patients, reaffirmed in the current guidelines from the American Heart Association (AHA) and
the American Stroke Association (ASA) for use within 4.5 hours of stroke initiation. However, fibrinolysis is associated with poor
vascular recanalization in cases of large vessel occlusion. Therefore, endovascular treatments have been developed to improve it.
Previous trials of endovascular treatment with initial devices failed to demonstrate a transcendent benefit beyond fibrinolysis alone.
Five trials that investigated the efficacy of moderns endovascular therapies, MR-CLEAN, ESCAPE, SWIFT-PRIME, EXTEND-IA and
REVASCAT, have been published, clarifying the vision of stroke management, providing strong evidences to support it. Based in the
clearly beneficial results of these trials, the AHA/ASA has updated its guidelines on endovascular treatment for stroke in 2015, giving
the strongest recommendation possible for selected patients to receive endovascular treatment. Recommending that stent retrievers
be used if possible, due to significantly improved functional outcomes results. Thanks to advances in technology and recent studies,
the endovascular therapy is now an irrefutable important resource in the treatment of acute ischemic stroke in the setting of large and
proximal vessel occlusion.
drjoaquinmd@hotmail.comOMICS J Radiol 2017, 6:6, (Suppl)
DOI: 10.4172/2167-7964-C1-019